Angled intraosseous access system

Information

  • Patent Grant
  • 12274469
  • Patent Number
    12,274,469
  • Date Filed
    Tuesday, August 24, 2021
    3 years ago
  • Date Issued
    Tuesday, April 15, 2025
    3 months ago
Abstract
An angled intraosseous access system including a guide block and/or a guide plate is disclosed. The system includes a driver having a body, and including a needle assembly rotatably coupled thereto, the needle assembly defining a needle axis. One of the guide block or the guide plate is configured to engage a skin surface and align the needle assembly axis at a predetermined angle relative to the skin surface to access the medullary cavity at the predetermined angle. Advantageously, the angled needle of the intraosseous access system can mitigate pain during infusion and mitigate backwalling.
Description
BACKGROUND

Intraosseous (IO) access devices can provide vascular access by penetrating surface tissues and underlying hard bone cortex layers to place an access needle and provide access to a medullary cavity of a bone. Fluids and medications can flow through the needle lumen and into the medullary cavity to infuse into the vascular system. IO access events are typically performed in emergent situations where vascular access is rapidly required and/or direct venous access is not possible.


Patients who require IO access report experiencing increased pain during infusion rather than during penetration of the skin surface tissues or bone cortex. The cause of pain may be due to increased pressure in the medullary cavity due to the infused fluids and/or medication. Angling the needle during insertion may direct medication towards larger volumes of the medullary cavity, e.g. the tibial tuberosity, reducing the pressure within the medullary cavity, and in turn reducing discomfort. Further, angling the needle during penetration can mitigate “backwalling,” where the access needle traverses the medullary cavity and penetrates the far wall of bone cortex. Disclosed herein are angled intraosseous access systems including an angled guide plate and an angled guide block, and associated methods thereof that address the foregoing.


SUMMARY

Disclosed herein is an angled intraosseous access system including, a needle assembly including a needle defining a needle axis and configured to access a medullary cavity of a bone, a driver rotatably coupled to the needle assembly and configured to advance the needle through a bone cortex to access the medullary cavity, and one or both of a guide plate and a guide block configured to engage a skin surface and align the needle axis at a predetermined angle relative to a longitudinal axis of the medullary cavity.


In some embodiments, the predetermined angle is between 1°-90° relative to the longitudinal axis of the medullary cavity. In some embodiments, one of the guide plate or the guide block includes a concave or convex skin engaging surface configured to engage the skin surface. In some embodiments, the guide plate is coupled to the guide block. In some embodiments, one of the guide plate or the guide block includes a guide recess configured to engage a fiduciary body part and align the needle with a target location. In some embodiments, the guide recess is disposed on a first portion that is slidably engaged with a second portion of one of the guide plate or the guide block which is coupled to the needle.


In some embodiments, the guide block includes a first series of notches and a second series of notches each configured to receive a portion of the driver, the first series of notches configured to align the needle axis with a first predetermined angle, the second series of notches configured to align the needle axis with a second predetermined angle different from the first predetermined angle. In some embodiments, the guide plate defines a channel configured to receive the needle therethrough and maintain the needle at the predetermined angle. In some embodiments, one of the guide plate or the guide block is releasably engaged with the driver body.


In some embodiments, one or both of the guide plate and the guide block includes an adhesive disposed on a surface thereof and configured to adhere to one or both of the driver and the skin surface. In some embodiments, a portion of the guide plate is configured to abut against a portion of the needle assembly to prevent a distal tip of the needle from backwalling a far wall of the medullary cavity.


Also disclosed is a method of accessing a medullary cavity including, engaging a skin engaging surface of a guide plate with a skin surface, aligning a needle of an intraosseous access system with a channel of the guide plate, the channel extending at a predetermined angle relative to the skin engaging surface, and advancing the needle through the channel to access the medullary cavity at the predetermined angle.


In some embodiments, the predetermined angle is between 1°-90° relative to a longitudinal axis of the medullary cavity. In some embodiments, the skin engaging surface includes a concave or a convex portion configured to engage the skin surface. In some embodiments, the method further includes coupling the guide plate with a guide block configured to engage the skin surface and a driver of the intraosseous access system and maintain an axis of the driver at the predetermined angle. In some embodiments, the method further includes engaging a guide recess, disposed on the skin engaging surface, with a fiduciary body part to align the needle with a target location.


In some embodiments, the method further includes sliding a first portion of the guide plate including the guide recess disposed thereon, relative to a second portion of the guide plate including the channel, to align the needle with a target location. In some embodiments, the method further includes adhering a portion of the guide plate to one of the driver or the skin surface. In some embodiments, the method further includes abutting a portion of a needle hub, coupled to the needle against a surface of the guide plate to prevent a distal tip of the needle from backwalling a far wall of the medullary cavity.


Also disclosed is a method of accessing a medullary cavity including, engaging a portion of a driver of an intraosseous access system with a surface of the guide block, engaging a skin engaging surface of the guide block with a skin surface, aligning an axis of a needle of the intraosseous access system with a predetermined angle, and advancing the needle along the needle axis to access the medullary cavity at the predetermined angle.


In some embodiments, the predetermined angle is between 1°-90° relative to a longitudinal axis of the medullary cavity. In some embodiments, the method further includes engaging a guide recess disposed on the skin engaging surface with a fiduciary body part to align the needle with a target location. In some embodiments, the method further includes sliding a first portion of the guide block including the guide recess disposed thereon, relative to a second portion of the guide block to align the needle with a target location. In some embodiments, the method further includes engaging the portion of the driver with one of a first series of notches or a second series of notches to align the axis of the needle axis with one of a first predetermined angle or a second predetermined angle, different from the first predetermined angle.


These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.





DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1A illustrates a perspective view of a guide plate angled IO access system, in accordance with some embodiments.



FIG. 1B illustrates close up detail of a needle engaged with an angled guide plate, in accordance with some embodiments.



FIG. 2 illustrates a side view of a guide block angled IO access system, in accordance with some embodiments.



FIG. 3 illustrates a side view of a combination angled IO access system including a guide plate and a guide block, in accordance with some embodiments.



FIG. 4 illustrates a side view of a combination angled IO access system including a guide block having a slidable portion, in accordance with some embodiments.



FIGS. 5A-5B illustrate side views of a guide block angled IO access system, in accordance with some embodiments.





DESCRIPTION

Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.


Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a needle disclosed herein includes a portion of the needle intended to be near a clinician when the needle is used on a patient. Likewise, a “proximal length” of, for example, the needle includes a length of the needle intended to be near the clinician when the needle is used on the patient. A “proximal end” of, for example, the needle includes an end of the needle intended to be near the clinician when the needle is used on the patient. The proximal portion, the proximal-end portion, or the proximal length of the needle can include the proximal end of the needle; however, the proximal portion, the proximal-end portion, or the proximal length of the needle need not include the proximal end of the needle. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the needle is not a terminal portion or terminal length of the needle.


With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a needle disclosed herein includes a portion of the needle intended to be near or in a patient when the needle is used on the patient. Likewise, a “distal length” of, for example, the needle includes a length of the needle intended to be near or in the patient when the needle is used on the patient. A “distal end” of, for example, the needle includes an end of the needle intended to be near or in the patient when the needle is used on the patient. The distal portion, the distal-end portion, or the distal length of the needle can include the distal end of the needle; however, the distal portion, the distal-end portion, or the distal length of the needle need not include the distal end of the needle. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the needle is not a terminal portion or terminal length of the needle.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.



FIGS. 1A-1B show embodiments of a guide plate angled intraosseous (IO) access system 100 configured to penetrate a bone cortex 72 and surface tissues 74 to access a medullary cavity 70. In an embodiment, the guide plate angled IO access system 100 generally includes an IO access system 110 and an angled guide plate (“guide plate”) 130. The IO access system 110 generally includes a driver 112 having a body 114, and a needle assembly 120 rotatably coupled to the driver 112. In an embodiment, the driver 112 includes an automatic driver or a manual driver configured to rotate the needle assembly 120 and drill a needle 124 through the surface tissues 74 and bone cortex 72, access a medullary cavity 70 of a bone of a patient.


In an embodiment, the driver 112 can include a drive spring, electric motor, or similar electrical, mechanical, electro-mechanical, or kinetic mechanism configured to rotate the needle assembly 120 and drill the needle assembly into a bone of a patient. In an embodiment, the needle assembly 120 can include a needle 124 defining a lumen and supported by a needle hub 126. The needle assembly 120 can further include an obturator 122 disposed within the lumen of the needle 124 and supported by an obturator hub 128. The obturator 122 can be configured to prevent tissue and bone fragments from entering the needle lumen during a placement event and occluding a fluid flow through the needle lumen. Once the needle 124 has been placed, the driver 110 and obturator 122 can be removed. Fluids and/or medications can flow through the needle lumen and into the medullary cavity 70 to infuse into the vasculature of the patient. Further details and embodiments of IO access systems can be found, for example in the following published applications: US 2021/0093354, US 2021/0093355, US 2021/0093358, US 2021/0093356, US 2021/0093357, US 2021/0137558, WO 2018/075694, WO 2018/165334, and WO 2018/165339, each of which are incorporated by reference in its entirety herein.


In an embodiment, the guide plate 130 includes a body 131 defining a skin engaging surface 138, and a channel 132 extending at an angle (θ) relative to a longitudinal axis of the body 131. In an embodiment, the skin engaging surface 138 can be a bottom surface of the body 131. However, it will be appreciated that the skin engaging surface 138 can include one or more surfaces of the body 131. In an embodiment, the skin engaging surface 138 of the guide plate 130 can engage a skin surface 76 and align the channel 132 at an angle (θ) relative thereto. In an embodiment, the guide plate 130 align the channel 132 at an angle (θ) relative to a longitudinal axis 60 of the medullary cavity 70. In an embodiment, the angle (θ) of the channel 132 can be between 1° and 90°. In an embodiment, the angle (θ) of the channel 132 can be between 10°-75°. In an embodiment, the angle (θ) of the channel 132 can be substantially 45°, however greater or lesser angles are also contemplated.


In an embodiment, a diameter of the channel 132 can be equal to or slightly larger than a diameter of the needle 124. As such, the needle 124 can slidably engage the channel 132 and substantially align an axis 62 of the needle 124 with an axis of the channel 132. In some embodiments, the diameter of the guide plate channel 132 may be a consistent diameter along the length thereof In some embodiments, the guide plate channel 132 or portion thereof may define a tapered shape, having a greater diameter proximate a first end relative to a second end, opposite the first end. In some embodiments, an entrance of the guide plate channel 132 may be tapered to facilitate aligning a needle 124 with the channel 132.


In an exemplary method of use, a user can engage a skin engaging surface 138 of the guide plate 130 with a skin surface 76 and align the channel 132 with a target insertion site. The user can then align the needle 124 with the channel 132 and advance a distal tip 129 of the needle 124 through the channel 132. Advancing the needle 124 through the channel 132 can align an axis 62 of the needle 124 with the axis of the channel 132. A user can then actuate the driver 112 to rotate the needle assembly 120 and “drill” the needle 124 into the patient. The needle 124 can then penetrate the surface tissues 74, hard bone cortex 72 and the medullary cavity 70 at the predetermined angle (θ) defined by the channel 132.


In an embodiment, the guide plate 130 can be coupled to the IO access system 110 and the guide plate 130 can be slidably engaged with the needle 124. As such, a user can support the skin engaging surface 138 against the skin surface 76 and the guide plate 130 can further support the IO access system 110 with the needle axis 62 aligned with the channel 132. The user can then actuate the driver 112 and urge the IO access system 110 including the needle 124 along the needle axis 62 at the predetermined angle (θ) defined by the channel 132. The needle 124 can slide through the channel 132 to penetrate the bone at the predetermined angle (θ), as described herein.


In an embodiment, the guide plate 130 can be coupled to the IO access system 110, and the needle assembly 120 can be slidably engaged relative to the IO access system 110 and guide plate 130 assembly. As such, a user can support the skin engaging surface 138 against the skin surface 76 and the guide plate 130 can further support the IO access system 110 with the needle axis 62 aligned with the channel 132. The user can then actuate the driver 112 and the IO access system 110 can urge the needle 124 along the needle axis 62 to penetrate the bone at the predetermined angle (θ), as described herein.


Advantageously, the insertion angle (θ) of the needle 124 can direct a fluid flow through the needle lumen towards the wider regions of the medullary cavity 70, for example at a head of the bone, and can reduce the pressure within the medullary cavity 70 as the fluids and/or medications are transfused. Advantageously, the guide plate 130 can be configured to align the needle 124 at an angle (θ) relative to the axis 60 of the medullary cavity 70 and can increase the penetrable depth (d) of the medullary cavity 70. As shown in FIG. 1A, for a given location within the medullary cavity 70, a perpendicular penetrable depth (d1) (i.e. when the needle is angled perpendicular to the axis 60 of the medullary cavity 70) is less than an angled penetrable depth (d2) (i.e. when the needle is angled (θ) relative to the medullary axis 60). As such, the angled penetrable depth (d2) mitigates the needle 124 from “backwalling” the far side of the medullary cavity 70. Further, in an embodiment, the guide plate 130 can be configured to align the needle 124 with the widest portion of the medullary cavity 70, e.g. at the head of the bone, as described in more detail herein.


In an embodiment, as shown in FIG. 1B, the length of the needle 124 extending between the needle hub 126 at a proximal end and a distal tip 129 can define a first length (L1). The channel 132 can define a second length (L2), less than the first length (L1), and extending axially. In an embodiment, the needle 124 can be advanced through the channel 132 until the distal tip 129 extends through the skin engaging surface 138 and a portion of the hub 126 abuts against a portion of the guide plate body 131, proximate the channel entrance 132. As such, with the skin engaging surface 138 contacting the skin surface 76, the distal tip 129 can extend through the channel 132 and penetrate the underlying tissues 74, bone cortex 72, etc. In an embodiment, the length (L2) of the channel 132 can be predetermined such that a portion of the needle 124 extends through the surface tissues 74, bone cortex 72 and into the medullary cavity 70 by a penetration length, or third length (L3). In an embodiment, the third length (L3) is the length of the needle (L1) less the length (L2) of the channel 132. Advantageously, the length (L1) of the needle 124 and the length (L2) of the channel 132 can be predetermined to ensure the penetration length (L3) of the needle 124 is less than a penetration length that would “backwall” the medullary cavity 70. This can prevent a user from over penetrating the needle 124 during an emergency placement event.


In an embodiment, as shown in FIG. 1B, the guide plate 130 can further include a needle hub slot 144 configured to receive a portion of the needle hub 144 therein. Advantageously, the needle hub slot 144 can be configured to facilitate aligning the axis 62 of the needle with axis of the channel 132. In an embodiment, the needle hub 126 can abut against a portion of the needle hub slot 144 to prevent the distal tip 129 of the needle 124 from extending beyond the predetermined penetrable length (L3), mitigating backwalling of the medullary cavity 70.


In an embodiment, as shown in FIG. 2, an angled IO access system 200 can include a guide block 230, configured to engage one or both of the IO access system 110 and the skin surface 76 and align the needle 124 at an angle (θ) relative to the skin surface 76 and/or an axis 60 of the medullary cavity 70. In an embodiment, the guide block 230 includes a body 231 having a skin engaging surface 238. In an embodiment, the skin engaging surface 238 can be a bottom surface of the body 231. However, it will be appreciated that the skin engaging surface 138 can include one or more surfaces of the body 231. Advantageously, the guide block 230 provides a stable surface for IO access system 110 to rest on.


In an embodiment, the guide block 230 can be integrally formed with the driver body 114. In an embodiment, the guide block 230 can be coupled to a portion of the driver body 114 using adhesive, bonding, welding, bolts, screws, or similar fasteners, or similar suitable means. In an embodiment, the guide block 230 can be releasably coupled with the driver body 114 using a clip, latch, interference fit, press-fit, or snap-fit engagement, or similar suitable mechanism.


In an embodiment, a user can grasp the driver body 114 with the guide block 230 coupled thereto, and engage the skin engaging surface 238 with the skin surface 76 of the patient. As such, an axis 62 of the needle 124 can be positioned at a predetermined angle (θ) relative to the axis 60 of the medullary cavity 70, as described herein.


In an embodiment, the IO access system 110 can be slidably engaged with the guide block 230 along the axis 62 of the needle 124. In an embodiment, the needle assembly 120 or portions thereof can be slidable relative to one or both of the driver 112 and the guide block 230, along the axis 62 of the needle 124. As such, the skin engaging surface 238 of the guide block 230 can engage the skin surface 76 and angle the axis 62 of the needle 124 relative to the axis 60 of the medullary cavity 70, as described herein. The needle 124 can then slide along the needle axis 62 through the surface tissues 74, bone cortex 72, and access the medullary cavity 70, as described herein.


In an embodiment, as shown in FIGS. 1A-2, one of the skin engaging surface 138 of the guide plate 130, or the skin engaging surface 238 of the guide block 230 can define a substantially flat surface. As shown in FIG. 3, in an embodiment, the skin engaging surface 138 of the guide plate 130, or the skin engaging surface 238 of the guide block 230 can include a regular or irregular concave or convex surface configured to substantially match a curved shape of a skin surface 76.


In an embodiment, as shown in FIG. 3, an angled IO access system 300 can include both the guide plate 130, and the guide block 230 to support and guide the IO access system 110 at a predetermined angle (θ) relative to the skin surface 76. In some embodiments, the guide plate 130 can be coupled to the guide block 230 to provide the user with a stable surface to rest a portion of the body 114 of the driver 112 and provide a guide for accessing the medullary cavity 70 at a predetermined angle (θ), as described herein.


In an embodiment, the guide plate 130 can be integrally formed with the guide block 230. In an embodiment, the guide plate 130 can be coupled to a portion of the guide block 230 using adhesive, bonding, welding, bolts, screws, or similar fasteners, or similar suitable means. In an embodiment, the guide plate 130 can be releasably coupled with the guide block 230 using a clip, latch, interference fit engagement, press-fit engagement, snap-fit engagement, hook, tab, slot, or similar suitable mechanism, or combinations thereof. Advantageously, the guide plate 130 and the guide block 230 being coupled together can offer increased stability during a medullary access event to ensure accurate placement of the access needle 124.


In an embodiment, one or more surfaces of the guide plate body 131 or the guide block body 231 can include an adhesive or the like. For example, the adhesive surface can be disposed on a skin engaging surface 138, 238 to facilitate securing the guide plate 130 or guide block 230 to the skin surface 76. In an embodiment, the adhesive surface can be configured to secure one or both of the guide plate 130 and the guide block 230 relative to the IO access system 110. In an embodiment, one or more surfaces of the guide plate 131 or the guide block body 231 can include a material, e.g. silicone rubber, or the like, having a high frictional coefficient to facilitate securing the guide plate 130 or guide block 230 relative to the skin surface 76, or to the IO access system 110, or combinations thereof.


As shown in FIG. 4, in an embodiment, one of the guide plate 130 or the guide block 230 can include a guide recess 290 configured to engage a fiduciary body part 78 and to facilitate alignment of the needle 124 with a target area of bone. For example, a skin engaging surface 238 of the guide block 230 can include a guide recess 290 configured to receive the fiduciary body part 78, e.g. ankle bone, wrist bone, or the like, and to facilitate alignment of the needle 124 with a target area of bone. The driver 112 can be coupled to the guide block 230 with a needle assembly 120 disposed proximate a first end 242. The guide recess 290 can be disposed on a skin engaging surface 238 proximate a second end 244, disposed opposite the first end 242 along an axis of the guide block 230 extending substantially parallel to the skin surface 76 or the axis 60 of the medullary cavity 70. In an embodiment, the guide recess 290 can be a regular or irregular concave shape and can be configured to engage a fiduciary body part 78, e.g. an ankle bone or the like. When the guide block 230 is aligned with the fiduciary body part 78, the needle 124 of the IO access system 110 will be aligned at an angle (θ) with a target area of bone, e.g. a tibial tuberosity, or the like.


Advantageously, the guide block 230 including the guide recess 290 can quickly and intuitively align the needle 124 with a target area of the bone, e.g. the widest portion of the medullary cavity 70, during an emergency placement event where time and availability of trained personnel may be limited. Further, the guide block 230 can angle the needle 124 relative to the axis 60 of the medullary cavity 70 to further increase a penetrable depth for the needle 124.


In an embodiment, a portion of the guide plate 130 or the guide block 230 can be slidably engaged therewith, to allow a user to adjust the position of the guide recess 290 relative to the needle 124. For example, as shown in FIG. 4, a first portion 230A of the guide block 230 that includes the guide recess 290 can be slidably engaged with a second portion 230B of the guide block 230 that supports the IO access system 110. As such, the distance between the guide recess 290 and the needle 124 of the IO access system 110 can be modified to suit different size bones of different patients. For example, taller patients may have a greater distance between the ankle body and the tibial tuberosity than shorter patients.


In an exemplary method of use, the guide plate 130 and guide block 230 assembly can engage a skin surface 76 of a patient. In an embodiment, a concave or convex skin engaging surface 138, 238 can engage a curved skin surface 76 of the patient. In an embodiment, a guide recess 290 can engage a fiduciary body part 78 to align the needle 124 with a target area. In an embodiment, the user can adjust a first portion 230A of the guide block 230 relative to a second portion 230B and engage the guide recess 290 with the fiduciary body part 78. In an embodiment, the user can align the needle 124 with the channel 132. In an embodiment, the needle 124 can be “preloaded” within the channel 132 prior to the system 300 engaging the skin surface 76. The user can then actuate the driver 112 to rotate the needle assembly 120. In an embodiment, the IO access system 100 can slide relative to one of the guide plate 130 or the guide block 230 to advance the needle 124 through the channel 132. In an embodiment, the needle assembly 120 can advance through the channel 132 relative to the driver 112. The needle can then penetrate the bone at the predetermined angle (θ) to access the medullary cavity 70, as described herein.



FIGS. 5A-5B show an embodiment of an adjustable angle IO access system 400 including a guide block 430 having a skin engaging surface 438 and one or more notches 432 disposed on one or more surfaces of the guide block 430. The one or more notches 432 can be configured to receive a portion of the driver body 114 and position the driver 112 at one or more predetermined angles relative to the axis 60 of the medullary cavity 70 when the skin engaging surface 438 engages a skin surface 76.


For example, as shown in FIG. 5A, a first series of notches 432A of the one or more notches 432 can receive one or more portions of the driver body 114 and position an axis 62 of the needle 124 at a first angle (θ1) relative to the skin surface 76 and/or medullary cavity axis 60. As shown in FIG. 5B, a second series of notches 432B of the one or more notches 432 can receive one or more portions of the driver body 114 and position an axis 62 of the needle 124 at a second angle (θ2) relative to the skin surface 76 and/or medullary cavity axis 60 different from the first angle (θ1). In an embodiment, one of the first angle (θ1) or the second angle (θ2) can be between 1°-90° relative to the axis 60 of the medullary cavity 70. In an embodiment, the guide block 430 can include one or more symbols, alphanumeric symbols, color codes, textures, or the like to indicate which series of notches 432 corresponds with which predetermined angles (θ1, θ2).


In an exemplary method of use, a skin engaging surface 438 of the guide block 430 can engage a skin surface 76 of the patient. The user can align a portion of the driver body 114 with one of the first series of notches 432A or the second series of notches 432B to selectively align an axis 62 of the needle 124 with one of the first angle (θ1) or the second angle (θ2). The user can then actuate the driver 112 to rotate the needle assembly 120 and advance the needle 124 into the medullary cavity 70, as described herein, at one of the first angle (θ1) or the second angle (θ2).


While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims
  • 1. An angled intraosseous access system, comprising: a needle assembly including a needle defining a needle axis and configured to access a medullary cavity of a bone;a driver rotatably coupled to the needle assembly and configured to advance the needle through a bone cortex to access the medullary cavity; anda guide plate and a guide block configured to engage a skin surface and align the needle axis at a predetermined angle relative to a longitudinal axis of the medullary cavity; wherein the guide block includes a first series of notches and a second series of notches each configured to receive a portion of the driver, the first series of notches configured to align the needle axis with a first predetermined angle, the second series of notches configured to align the needle axis with a second predetermined angle different from the first predetermined angle.
  • 2. The angled intraosseous access system according to claim 1, wherein the predetermined angle is between 1°-90° relative to the longitudinal axis of the medullary cavity.
  • 3. The angled intraosseous access system according to claim 1, wherein one of the guide plate or the guide block includes a concave or convex skin engaging surface configured to engage the skin surface.
  • 4. The angled intraosseous access system according to claim 1, wherein the guide plate is coupled to the guide block.
  • 5. The angled intraosseous access system according to claim 1, wherein one of the guide plate or the guide block includes a guide recess configured to engage a an anatomical landmark body part and align the needle with a target location.
  • 6. The angled intraosseous access system according to claim 5, wherein the guide recess is disposed on a first portion that is slidably engaged with a second portion of one of the guide plate or the guide block which is coupled to the needle.
  • 7. The angled intraosseous access system according to claim 1, wherein the guide plate defines a channel configured to receive the needle therethrough and maintain the needle at the predetermined angle.
  • 8. The angled intraosseous access system according to claim 1, wherein one of the guide plate or the guide block is releasably engaged with a driver body.
  • 9. The angled intraosseous access system according to claim 1, wherein one or both of the guide plate and the guide block includes an adhesive disposed on a surface thereof and configured to adhere to one or both of the driver and the skin surface.
  • 10. The angled intraosseous access system according to claim 1, wherein a portion of the guide plate is configured to abut against a portion of the needle assembly to prevent a distal tip of the needle from backwalling a far wall of the medullary cavity.
  • 11. A method of accessing a medullary cavity, comprising: engaging a skin engaging surface of a guide plate with a skin surface;aligning a needle of an intraosseous access system with a channel of the guide plate, the channel extending at a predetermined angle relative to the skin engaging surface;engaging a guide recess, disposed on the skin engaging surface, with an anatomical landmark body part;sliding a first portion of the guide plate including the guide recess disposed thereon, relative to a second portion of the guide plate including the channel, to align the needle with a target location; andadvancing the needle through the channel to access the medullary cavity at the predetermined angle.
  • 12. The method according to claim 11, wherein the predetermined angle is between 1°-90° relative to a longitudinal axis of the medullary cavity.
  • 13. The method according to claim 11, wherein the skin engaging surface includes a concave or a convex portion configured to engage the skin surface.
  • 14. The method according to claim 11, further including coupling the guide plate with a guide block configured to engage the skin surface and a driver of the intraosseous access system and maintain an axis of the driver at the predetermined angle.
  • 15. The method according to claim 11, wherein the predetermined angle is less than or equal to 45°.
  • 16. The method according to claim 11, further including adhering a portion of the guide plate to one of a driver or the skin surface.
  • 17. The method according to claim 11, further including abutting a portion of a needle hub, coupled to the needle against a surface of the guide plate to prevent a distal tip of the needle from backwalling a far wall of the medullary cavity.
  • 18. A method of accessing a medullary cavity, comprising: engaging a portion of a driver of an intraosseous access system with a surface of a guide block, the driver including a needle;engaging a skin engaging surface of the guide block with a skin surface; aligning an axis of the needle of the intraosseous access system with a predetermined angle; engaging the portion of the driver with a first series of notches to align the axis of the needle with a first predetermined angle or engaging the portion of the driver with a second series of notches to align the axis of the needle with a second predetermined angle different from the first predetermined angle; andadvancing the needle along the needle axis to access the medullary cavity at the predetermined angle.
  • 19. The method according to claim 18, wherein the predetermined angle is between 1°-90° relative to a longitudinal axis of the medullary cavity.
  • 20. The method according to claim 18, further including engaging a guide recess disposed on the skin engaging surface with an anatomical landmark body part to align the needle with a target location.
  • 21. The method according to claim 20, further including sliding a first portion of the guide block including the guide recess disposed thereon, relative to a second portion of the guide block to align the needle with the target location.
  • 22. The method according to claim 18, wherein the first predetermined angle is less than 90° and wherein the second predetermined angle is less than 45°.
PRIORITY

This application claims the benefit of priority to U.S. Provisional Application No. 63/069,988, filed Aug. 25, 2020, which is incorporated by reference in its entirety into this application.

US Referenced Citations (382)
Number Name Date Kind
2773501 Young Dec 1956 A
3071135 Baldwin et al. Jan 1963 A
3261594 Michel Jul 1966 A
3734207 Fishbein May 1973 A
3753432 Guerra Aug 1973 A
3804544 Adams Apr 1974 A
3811442 Maroth May 1974 A
3815605 Schmidt et al. Jun 1974 A
3991765 Cohen Nov 1976 A
4266555 Jamshidi May 1981 A
4314565 Lee Feb 1982 A
4342724 Narra Aug 1982 A
4381777 Garnier May 1983 A
4383530 Bruno May 1983 A
4562844 Carpenter et al. Jan 1986 A
4736742 Alexson et al. Apr 1988 A
4787893 Villette Nov 1988 A
4889529 Haindl Dec 1989 A
4952207 Lemieux Aug 1990 A
4964854 Luther Oct 1990 A
4969870 Kramer et al. Nov 1990 A
5040542 Gray Aug 1991 A
5042558 Hussey et al. Aug 1991 A
5053017 Chamuel Oct 1991 A
5122114 Miller et al. Jun 1992 A
5207697 Carusillo et al. May 1993 A
5263939 Wortrich Nov 1993 A
5290267 Zimmermann Mar 1994 A
5312364 Jacobs May 1994 A
5332398 Miller et al. Jul 1994 A
5364367 Banks et al. Nov 1994 A
5372583 Roberts et al. Dec 1994 A
5384103 Miller Jan 1995 A
5406940 Melzer et al. Apr 1995 A
5451210 Kramer et al. Sep 1995 A
5554154 Rosenberg Sep 1996 A
5575780 Saito Nov 1996 A
5591188 Waisman Jan 1997 A
5601559 Melker et al. Feb 1997 A
5667509 Westin Sep 1997 A
5688249 Chang et al. Nov 1997 A
5694019 Uchida et al. Dec 1997 A
5779708 Wu Jul 1998 A
5817052 Johnson et al. Oct 1998 A
5853393 Bogert Dec 1998 A
5868711 Kramer Feb 1999 A
5885293 McDevitt Mar 1999 A
5927976 Wu Jul 1999 A
5960797 Kramer et al. Oct 1999 A
5967143 Klappenberger Oct 1999 A
6018227 Kumar et al. Jan 2000 A
6056165 Speranza May 2000 A
6104162 Sainsbury et al. Aug 2000 A
6117108 Woehr et al. Sep 2000 A
6135769 Kwan Oct 2000 A
6159161 Hodosh Dec 2000 A
6199664 Tkaczyk et al. Mar 2001 B1
6210373 Allmon Apr 2001 B1
6228088 Miller et al. May 2001 B1
6247928 Meller et al. Jun 2001 B1
6270484 Yoon Aug 2001 B1
6273715 Meller et al. Aug 2001 B1
6419490 Kitchings Weathers, Jr. Jul 2002 B1
6458117 Pollins, Sr. Oct 2002 B1
6527778 Athanasiou et al. Mar 2003 B2
6547561 Meller et al. Apr 2003 B2
6602214 Heinz et al. Aug 2003 B2
6626887 Wu Sep 2003 B1
6629959 Kuracina et al. Oct 2003 B2
6641395 Kumar et al. Nov 2003 B2
6652490 Howell Nov 2003 B2
6692471 Boudreaux Feb 2004 B2
6761726 Findlay et al. Jul 2004 B1
6814734 Chappuis et al. Nov 2004 B2
6830562 Mogensen et al. Dec 2004 B2
6875219 Arramon et al. Apr 2005 B2
6905486 Gibbs Jun 2005 B2
6916292 Morawski et al. Jul 2005 B2
6984213 Horner et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
7112191 Daga Sep 2006 B2
7135031 Flint Nov 2006 B2
7214208 Vaillancourt et al. May 2007 B2
7347838 Kulli Mar 2008 B2
7347840 Findlay et al. Mar 2008 B2
7407493 Cane' Aug 2008 B2
7458954 Ferguson et al. Dec 2008 B2
7513888 Sircom et al. Apr 2009 B2
7530965 Villa et al. May 2009 B2
7534227 Kulli May 2009 B2
7569033 Greene et al. Aug 2009 B2
7582102 Heinz et al. Sep 2009 B2
7588559 Aravena et al. Sep 2009 B2
7658725 Bialecki et al. Feb 2010 B2
7670328 Miller Mar 2010 B2
7699807 Faust et al. Apr 2010 B2
7699850 Miller Apr 2010 B2
7736332 Carlyon et al. Jun 2010 B2
7749225 Chappuis et al. Jul 2010 B2
7798994 Brimhall Sep 2010 B2
7811260 Miller et al. Oct 2010 B2
7815642 Miller Oct 2010 B2
7828774 Harding et al. Nov 2010 B2
7833204 Picha Nov 2010 B2
7842038 Haddock et al. Nov 2010 B2
7850620 Miller et al. Dec 2010 B2
7850650 Breitweiser Dec 2010 B2
D633199 MacKay et al. Feb 2011 S
7899528 Miller et al. Mar 2011 B2
7905857 Swisher Mar 2011 B2
7951089 Miller May 2011 B2
7955297 Radmer et al. Jun 2011 B2
7972339 Nassiri et al. Jul 2011 B2
7976502 Baid Jul 2011 B2
8038038 Hillhouse et al. Oct 2011 B2
8038664 Miller et al. Oct 2011 B2
8043253 Kraft et al. Oct 2011 B2
8043265 Abe et al. Oct 2011 B2
8142365 Miller Mar 2012 B2
8152771 Mogensen et al. Apr 2012 B2
8162904 Takano et al. Apr 2012 B2
8167899 Justis et al. May 2012 B2
8235945 Baid Aug 2012 B2
8246584 Aravena et al. Aug 2012 B2
8273053 Saltzstein Sep 2012 B2
8292891 Browne et al. Oct 2012 B2
8308693 Miller et al. Nov 2012 B2
8333769 Browne et al. Dec 2012 B2
8356598 Rumsey Jan 2013 B2
8357163 Sidebotham et al. Jan 2013 B2
8388541 Messerly et al. Mar 2013 B2
8388623 Browne et al. Mar 2013 B2
8414539 Kuracina et al. Apr 2013 B1
8419683 Miller et al. Apr 2013 B2
8480632 Miller et al. Jul 2013 B2
8480672 Browne et al. Jul 2013 B2
8486027 Findlay et al. Jul 2013 B2
8506568 Miller Aug 2013 B2
8535271 Fuchs et al. Sep 2013 B2
8562615 Browne et al. Oct 2013 B2
8641715 Miller Feb 2014 B2
8647257 Jansen et al. Feb 2014 B2
8656929 Miller et al. Feb 2014 B2
8657790 Tal et al. Feb 2014 B2
8663231 Browne et al. Mar 2014 B2
8668698 Miller et al. Mar 2014 B2
8684978 Miller et al. Apr 2014 B2
8690791 Miller Apr 2014 B2
8715287 Miller May 2014 B2
8771230 White et al. Jul 2014 B2
8781555 Burnside et al. Jul 2014 B2
8801663 Woehr Aug 2014 B2
8812101 Miller et al. Aug 2014 B2
8814835 Baid Aug 2014 B2
8821493 Anderson Sep 2014 B2
8828001 Stearns et al. Sep 2014 B2
8849382 Cox et al. Sep 2014 B2
8870872 Miller Oct 2014 B2
8894654 Anderson Nov 2014 B2
8936575 Moulton Jan 2015 B2
8944069 Miller et al. Feb 2015 B2
8974410 Miller et al. Mar 2015 B2
8998848 Miller et al. Apr 2015 B2
9072543 Miller et al. Jul 2015 B2
9078637 Miller Jul 2015 B2
9149625 Woehr et al. Oct 2015 B2
9173679 Tzachar et al. Nov 2015 B2
9226756 Teisen et al. Jan 2016 B2
9278195 Erskine Mar 2016 B2
9295487 Miller et al. Mar 2016 B2
9302077 Domonkos et al. Apr 2016 B2
9314232 Stark Apr 2016 B2
9314270 Miller Apr 2016 B2
9358348 Weilbacher et al. Jun 2016 B2
9393031 Miller Jul 2016 B2
9414815 Miller et al. Aug 2016 B2
9415192 Kuracina et al. Aug 2016 B2
9421345 Woehr et al. Aug 2016 B2
9427555 Baid Aug 2016 B2
9433400 Miller Sep 2016 B2
9439667 Miller Sep 2016 B2
9439702 Arthur et al. Sep 2016 B2
9445743 Kassab Sep 2016 B2
9451968 Miller et al. Sep 2016 B2
9451983 Windolf Sep 2016 B2
9456766 Cox et al. Oct 2016 B2
9480483 Browne et al. Nov 2016 B2
9492097 Wilkes et al. Nov 2016 B2
9504477 Miller et al. Nov 2016 B2
9521961 Silverstein et al. Dec 2016 B2
9545243 Miller et al. Jan 2017 B2
9554716 Burnside et al. Jan 2017 B2
9615816 Woodard Apr 2017 B2
9615838 Nino et al. Apr 2017 B2
9623210 Woehr Apr 2017 B2
9636031 Cox May 2017 B2
9636484 Baid May 2017 B2
9649048 Cox et al. May 2017 B2
9681889 Greenhalgh et al. Jun 2017 B1
9687633 Teoh Jun 2017 B2
9717564 Miller et al. Aug 2017 B2
9730729 Kilcoin et al. Aug 2017 B2
9782546 Woehr Oct 2017 B2
9839740 Beamer et al. Dec 2017 B2
9844646 Knutsson Dec 2017 B2
9844647 Knutsson Dec 2017 B2
9872703 Miller et al. Jan 2018 B2
9883853 Woodard et al. Feb 2018 B2
9895512 Kraft et al. Feb 2018 B2
9962211 Csernatoni May 2018 B2
10052111 Miller et al. Aug 2018 B2
10092320 Morgan et al. Oct 2018 B2
10092706 Denzer et al. Oct 2018 B2
10159531 Misener et al. Dec 2018 B2
10172538 Kassab Jan 2019 B2
10413211 Kassab Sep 2019 B2
10449330 Newman et al. Oct 2019 B2
D898908 Denzer et al. Oct 2020 S
10893887 Blanchard Jan 2021 B2
10973532 Miller et al. Apr 2021 B2
10973545 Miller et al. Apr 2021 B2
10980522 Muse Apr 2021 B2
11298202 Miller et al. Apr 2022 B2
11446112 Fink et al. Sep 2022 B2
11896264 Lindekugel et al. Feb 2024 B2
20030060781 Mogensen et al. Mar 2003 A1
20030225344 Miller Dec 2003 A1
20030225411 Miller Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20040010236 Morawski et al. Jan 2004 A1
20040059317 Hermann Mar 2004 A1
20040220497 Findlay et al. Nov 2004 A1
20040243135 Koseki Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050101912 Faust et al. May 2005 A1
20050113866 Heinz et al. May 2005 A1
20050131345 Miller Jun 2005 A1
20050165403 Miller Jul 2005 A1
20060015066 Turieo et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060025723 Ballarini Feb 2006 A1
20060058826 Evans et al. Mar 2006 A1
20070049945 Miller Mar 2007 A1
20070096690 Casalena et al. May 2007 A1
20070151116 Malandain Jul 2007 A1
20070191772 Wojcik Aug 2007 A1
20070270775 Miller et al. Nov 2007 A1
20070276352 Crocker et al. Nov 2007 A1
20070282344 Yedlicka et al. Dec 2007 A1
20080015467 Miller Jan 2008 A1
20080154304 Crawford et al. Jun 2008 A1
20080208136 Findlay et al. Aug 2008 A1
20080215056 Miller et al. Sep 2008 A1
20080221580 Miller et al. Sep 2008 A1
20080257359 Rumsey Oct 2008 A1
20090048575 Waters Feb 2009 A1
20090054808 Miller Feb 2009 A1
20090093830 Miller Apr 2009 A1
20090194446 Miller et al. Aug 2009 A1
20090204024 Miller Aug 2009 A1
20090306697 Fischvogt Dec 2009 A1
20100004606 Hansen et al. Jan 2010 A1
20100174243 McKay Jul 2010 A1
20100204649 Miller et al. Aug 2010 A1
20100286607 Saltzstein Nov 2010 A1
20100298830 Browne et al. Nov 2010 A1
20100298831 Browne et al. Nov 2010 A1
20100312246 Browne et al. Dec 2010 A1
20110004163 Vaidya Jan 2011 A1
20110028976 Miller Feb 2011 A1
20110202065 Takizawa et al. Aug 2011 A1
20120116390 Madan May 2012 A1
20120116394 Timm et al. May 2012 A1
20120202180 Stock et al. Aug 2012 A1
20120203154 Tzachar Aug 2012 A1
20120274280 Yip et al. Nov 2012 A1
20130030439 Browne et al. Jan 2013 A1
20130041345 Kilcoin et al. Feb 2013 A1
20130072938 Browne et al. Mar 2013 A1
20130102924 Findlay et al. Apr 2013 A1
20130158484 Browne et al. Jun 2013 A1
20130178807 Baid Jul 2013 A1
20140031674 Newman et al. Jan 2014 A1
20140031794 Windolf Jan 2014 A1
20140039400 Browne et al. Feb 2014 A1
20140081281 Felder Mar 2014 A1
20140142577 Miller May 2014 A1
20140171873 Mark Jun 2014 A1
20140188133 Misener Jul 2014 A1
20140221970 Eaton et al. Aug 2014 A1
20140262408 Woodard Sep 2014 A1
20140262880 Yoon Sep 2014 A1
20140276205 Miller et al. Sep 2014 A1
20140276206 Woodward et al. Sep 2014 A1
20140276471 Emery et al. Sep 2014 A1
20140276833 Larsen et al. Sep 2014 A1
20140276839 Forman et al. Sep 2014 A1
20140343454 Miller et al. Nov 2014 A1
20140343497 Baid Nov 2014 A1
20150011941 Saeki Jan 2015 A1
20150045732 Murphy et al. Feb 2015 A1
20150080762 Kassab et al. Mar 2015 A1
20150126931 Holm et al. May 2015 A1
20150196737 Baid Jul 2015 A1
20150223786 Morgan et al. Aug 2015 A1
20150230823 Morgan et al. Aug 2015 A1
20150238733 Bin Abdulla Aug 2015 A1
20150342615 Keinan et al. Dec 2015 A1
20150342756 Bays et al. Dec 2015 A1
20150351797 Miller et al. Dec 2015 A1
20150366569 Miller Dec 2015 A1
20150367487 Nino et al. Dec 2015 A1
20160009812 Satelli et al. Jan 2016 A1
20160022282 Miller et al. Jan 2016 A1
20160022284 Lele et al. Jan 2016 A1
20160039916 Jiang et al. Feb 2016 A1
20160058432 Miller Mar 2016 A1
20160066954 Miller et al. Mar 2016 A1
20160136410 Aklog et al. May 2016 A1
20160183974 Miller Jun 2016 A1
20160184509 Miller et al. Jun 2016 A1
20160235949 Baid Aug 2016 A1
20160305497 Victor et al. Oct 2016 A1
20160354539 Tan et al. Dec 2016 A1
20160361519 Teoh et al. Dec 2016 A1
20170020533 Browne et al. Jan 2017 A1
20170020560 Van Citters et al. Jan 2017 A1
20170021138 Sokolski Jan 2017 A1
20170043135 Knutsson Feb 2017 A1
20170105763 Karve et al. Apr 2017 A1
20170136217 Riesenberger et al. May 2017 A1
20170151419 Sonksen Jun 2017 A1
20170156740 Stark Jun 2017 A9
20170156751 Csernatoni Jun 2017 A1
20170209129 Fagundes et al. Jul 2017 A1
20170231644 Anderson Aug 2017 A1
20170303962 Browne et al. Oct 2017 A1
20170303963 Kilcoin et al. Oct 2017 A1
20180049772 Brockman et al. Feb 2018 A1
20180092662 Rioux et al. Apr 2018 A1
20180116551 Newman et al. May 2018 A1
20180116642 Woodard et al. May 2018 A1
20180116693 Blanchard et al. May 2018 A1
20180117262 Islam May 2018 A1
20180125465 Muse et al. May 2018 A1
20180153474 Aeschlimann et al. Jun 2018 A1
20180154112 Chan et al. Jun 2018 A1
20180221003 Hibner et al. Aug 2018 A1
20180228509 Fojtik Aug 2018 A1
20180242982 Laughlin et al. Aug 2018 A1
20190059986 Shelton, IV et al. Feb 2019 A1
20190069812 Isaacson et al. Mar 2019 A1
20190083753 Chu Mar 2019 A1
20190150954 Xie May 2019 A1
20190175220 Coppedge et al. Jun 2019 A1
20190282244 Muse Sep 2019 A1
20200054347 Coppedge et al. Feb 2020 A1
20200054410 Pfotenhauer et al. Feb 2020 A1
20200113584 McGinley et al. Apr 2020 A1
20200129186 Miller et al. Apr 2020 A1
20200197121 Morey et al. Jun 2020 A1
20200297382 Coppedge et al. Sep 2020 A1
20200297452 Coppedge et al. Sep 2020 A1
20200337782 Glassman et al. Oct 2020 A1
20210015529 Fenton, Jr. Jan 2021 A1
20210093357 Pett et al. Apr 2021 A1
20210093358 Lindekugel et al. Apr 2021 A1
20210113251 Vogt et al. Apr 2021 A1
20210282812 Tierney et al. Sep 2021 A1
20210322055 Lindekugel et al. Oct 2021 A1
20210375445 Lindekugel et al. Dec 2021 A1
20210393337 Zucker Dec 2021 A1
20220240976 Pett et al. Aug 2022 A1
20220249104 Pett et al. Aug 2022 A1
20220273338 Eisenthal et al. Sep 2022 A1
20230106545 Pett et al. Apr 2023 A1
20230285049 Howell Sep 2023 A1
20230414251 Pett et al. Dec 2023 A1
20240058036 Lindekugel et al. Feb 2024 A1
20240206887 Pett et al. Jun 2024 A1
20240261554 Akerele-Ale et al. Aug 2024 A1
20240277375 Lindekugel et al. Aug 2024 A1
Foreign Referenced Citations (67)
Number Date Country
108742795 Nov 2018 CN
110547847 Dec 2019 CN
0923961 Jun 1999 EP
3687024 Jul 2020 EP
2390297 Nov 2012 ES
2581548 Nov 1986 FR
2018509969 Apr 2018 JP
20090006621 Jan 2009 KR
2007018809 Feb 2007 NO
1997024151 Jul 1997 WO
1998052638 Feb 1999 WO
2005046769 May 2005 WO
05041790 May 2005 WO
2005053506 Jun 2005 WO
2005072625 Aug 2005 WO
2008002961 Jan 2008 WO
2008016757 Feb 2008 WO
2008033871 Mar 2008 WO
2008033872 Mar 2008 WO
2008033873 Mar 2008 WO
2008033874 Mar 2008 WO
2008054894 May 2008 WO
2008086258 Jul 2008 WO
2008124206 Oct 2008 WO
2008124463 Oct 2008 WO
2008130893 Oct 2008 WO
2008134355 Nov 2008 WO
2008144379 Nov 2008 WO
2009070896 Jun 2009 WO
2010043043 Apr 2010 WO
2011070593 Jun 2011 WO
2011097311 Aug 2011 WO
2011139294 Nov 2011 WO
2013003885 Jan 2013 WO
2013009901 Jan 2013 WO
2013173360 Nov 2013 WO
2014075165 May 2014 WO
2014142948 Sep 2014 WO
2014144239 Sep 2014 WO
2014144262 Sep 2014 WO
2014144489 Sep 2014 WO
2014144757 Sep 2014 WO
2014144797 Sep 2014 WO
2015061370 Apr 2015 WO
2015177612 Nov 2015 WO
2016033016 Mar 2016 WO
16053834 Apr 2016 WO
2016085973 Jun 2016 WO
2016163939 Oct 2016 WO
18006045 Jan 2018 WO
2018025094 Feb 2018 WO
2018058036 Mar 2018 WO
2018075694 Apr 2018 WO
18098086 May 2018 WO
2018165334 Sep 2018 WO
2018165339 Sep 2018 WO
2019051343 Mar 2019 WO
2019164990 Aug 2019 WO
2021011795 Jan 2021 WO
2021016122 Jan 2021 WO
2021062385 Apr 2021 WO
2021062038 Apr 2021 WO
2021062394 Apr 2021 WO
2022165232 Aug 2022 WO
2022170269 Aug 2022 WO
2023177634 Sep 2023 WO
2024163884 Aug 2024 WO
Non-Patent Literature Citations (57)
Entry
PCT/US2024/014241 filed Feb. 2, 2024 International Search Report and Written Opinion dated May 8, 2024.
U.S. Appl. No. 17/335,870, filed Jun. 1, 2021 Final Office Action dated Mar. 26, 2024.
U.S. Appl. No. 17/405,692, filed Aug. 18, 2021 Restriction Requirement dated May 10, 2024.
U.S. Appl. No. 18/385,056, filed Oct. 30, 2023 Non-Final Office Action dated May 9, 2024.
U.S. Appl. No. 17/031,650, filed Sep. 24, 2020 Non-Final Office Action dated Jan. 19, 2022.
PCT/US2021/ 046573 filed Aug. 18, 2021 International Search Report and Written Opinion dated Nov. 30, 2021.
PCT/US2021/ 047378 filed Aug. 24, 2021 International Search Report and Written Opinion dated Nov. 17, 2021.
PCT/US2021/ 048542 filed Aug. 31, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
PCT/US2021/ 049475 filed Sep. 8, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
EP 19757667.1 filed Sep. 18, 2020 Extended European Search Report dated Oct. 22, 2021.
EP 20867024.0 filed Apr. 21, 2022 Extended European Search Report dated Aug. 8, 2023.
EP 20868351.6 filed Apr. 21, 2022 Extended European Search Report dated Aug. 10, 2023.
EP 23166984.7 filed Apr. 6, 2023 Extended European Search Report dated Jul. 5, 2023.
PCT/US2023/015127 filed Mar. 13, 2023 International Search Report and Written Opinion dated Jun. 26, 2023.
U.S. Appl. No. 17/035,272, filed Sep. 28, 2020 Notice of Allowance dated Jul. 7, 2023.
U.S. Appl. No. 17/235,134, filed Apr. 20, 2021 Non-Final Office Action dated Jun. 27, 2023.
U.S. Appl. No. 17/335,870, filed Jun. 1, 2021 Restriction Requirement dated Jul. 25, 2023.
U.S. Appl. No. 17/667,291, filed Feb. 8, 2022 Non-Final Office Action dated Aug. 31, 2023.
U.S. Appl. No. 17/337,100, filed Jun. 2, 2021 Notice of Allowance dated Jan. 24, 2024.
U.S. Appl. No. 17/469,613, filed Sep. 8, 2021 Non-Final Office Action dated Jan. 19, 2024.
Ekchian Gregory James et al: “Quantitative Methods for In Vitro and In Vivo Characterization of Cell and Tissue Metabolism”, Jun. 11, 2018, XP055839281, retrieved from the internet on Sep. 8, 2021 : URL: https://dspace.mit.edu/bitstream/handle/1721.1/117890/1051211749-MIT.pdf?sequence=1&isAllowed=y.
PCT/US2019/ 018828 filed Feb. 20, 2019 International Preliminary Report on Patentability dated Aug. 27, 2020.
PCT/US2019/ 018828 filed Feb. 20, 2019 International Search Report and Written Opinion dated Jun. 13, 2019.
PCT/US2020/ 053119 filed Sep. 28, 2020 International Search Report and Written Opinion dated Jan. 5, 2021.
PCT/US2020/052558 filed Sep. 24, 2020 International Search Report and Written Opinion dated Feb. 11, 2021.
PCT/US2020/053135 filed Sep. 28, 2020 International Search Report and Written Opinion dated Dec. 18, 2020.
PCT/US2021/ 035232 filed Jun. 1, 2021 International Search Report and Written Opinion dated Oct. 19, 2021.
PCT/US2021/028114 filed Apr. 20, 2021 International Search Report and Written Opinion dated Jul. 12, 2021.
PCT/US2021/035475 filed Jun. 2, 2021 International Search Report and Written Opinion dated Sep. 17, 2021.
PCT/US2022/014391 filed Jan. 28, 2022 International Search Report and Written Opinion dated Apr. 14, 2022.
PCT/US2022/015686 filed Feb. 8, 2022 International Search Report and Written Opinion dated May 25, 2022.
U.S. Appl. No. 17/031,650, filed Sep. 24, 2020 Final Office Action dated Jul. 20, 2022.
U.S. Appl. No. 17/035,336, filed Sep. 28, 2020 Restriction Requirement dated Jul. 26, 2022.
U.S. Appl. No. 17/235,134, filed Apr. 20, 2021 Notice of Allowance dated Sep. 20, 2023.
U.S. Appl. No. 17/335,870, filed Jun. 1, 2021 Non-Final Office Action dated Nov. 15, 2023.
U.S. Appl. No. 17/337,100, filed Jun. 2, 2021 Final Office Action dated Nov. 21, 2023.
U.S. Appl. No. 17/469,613, filed Sep. 8, 2021 Restriction Requirement dated Oct. 23, 2023.
U.S. Appl. No. 17/863,898, filed Jul. 13, 2022 Final Office Action dated Nov. 22, 2023.
U.S. Appl. No. 17/031,650, filed Sep. 24, 2020 Notice of Allowance dated Oct. 12, 2022.
U.S. Appl. No. 17/035,272, filed Sep. 28, 2020 Non-Final Office Action dated Mar. 9, 2023.
U.S. Appl. No. 17/035,272, filed Sep. 28, 2020 Restriction Requirement dated Dec. 9, 2022.
U.S. Appl. No. 17/035,336, filed Sep. 28, 2020 Notice of Allowance dated Jan. 11, 2023.
U.S. Appl. No. 17/235,134, filed Apr. 20, 2021 Restriction Requirement dated Mar. 7, 2023.
U.S. Appl. No. 17/337,100, filed Jun. 2, 2021 Non-Final Office Action dated Jun. 2, 2023.
U.S. Appl. No. 17/667,291, filed Feb. 8, 2022 Restriction Requirement dated May 31, 2023.
U.S. Appl. No. 17/405,692, filed Aug. 18, 2021 Non-Final Office Action dated Sep. 6, 2024.
U.S. Appl. No. 17/463,324, filed Aug. 31, 2021 Non-Final Office Action dated Oct. 30, 2024.
U.S. Appl. No. 17/463,324, filed Aug. 31, 2021 Restriction Requirement dated Aug. 8, 2024.
U.S. Appl. No. 17/587,900, filed Jan. 28, 2022 Non-Final Office Action dated Nov. 14, 2024.
U.S. Appl. No. 18/075,269, filed Dec. 5, 2022 Non-Final Office Action dated Jun. 24, 2024.
U.S. Appl. No. 18/075,269, filed Dec. 5, 2022 Notice of Allowance dated Sep. 11, 2024.
U.S. Appl. No. 18/244,730, filed Sep. 11, 2023 Final Office Action dated Aug. 8, 2024.
U.S. Appl. No. 18/244,730, filed Sep. 11, 2023 Non-Final Office Action dated May 3, 2024.
U.S. Appl. No. 18/244,730, filed Sep. 11, 2023 Notice of Allowance dated Oct. 24, 2024.
U.S. Appl. No. 18/385,056, filed Oct. 30, 2023 Notice of Allowance dated Aug. 29, 2024.
U.S. Appl. No. 17/405,692, filed Aug. 18, 2021 Final Office Action dated Dec. 4, 2024.
U.S. Appl. No. 17/469,613, filed Sep. 8, 2021 Final Office Action dated Dec. 6, 2024.
Related Publications (1)
Number Date Country
20220061880 A1 Mar 2022 US
Provisional Applications (1)
Number Date Country
63069988 Aug 2020 US